About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

BioAge partners with Age Labs to study healthy life length

Oncolyze seeking investment for AML clinical trials

Amgen announces top-line results from biosimilar phase 3 study

Northwest Biotherapeutics’ pediatric investigation plan approved by MHRA

Freedom Biosciences exits stealth with $10.5M financing to develop mental health treatments

Novel nanotechnology ‘supercharges’ immune system molecules to fight cancer

ADVERTISEMENT

BioInnovation Institute launches new program and takes on four companies

Parkinson’s Foundation and Parkinson’s UK partner to drive drug development

Gate Neurosciences emerges from stealth to tackle CNS diseases

Alume Biosciences progressing with fluorescence study in patients undergoing head and neck surgery

Ocelot Bio receives FDA Orphan Drug Designation for lead candidate for treatment of hepatorenal syndrome

Institute for Bioscience and Biotechnology Research awarded $6.9M to work on hepatitis C vaccine

ADVERTISEMENT